InsidersTradesSigma
Browse the complete record of transactions filed by Ganjei James Kelly, Director. Officer active across 1 companies, notably Inmune Bio, Inc.. Aggregated, 1 filings have been recorded. The latest transaction was filed on 22 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
James Kelly Ganjei is a Director at Inmune Bio, Inc. He is involved in overseeing the company's activities and contributes to defining its strategy. His industry experience allows him to provide valuable insights to the board.